The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical update related to the first-in-human trial of SYS6002 (CRB-701), a next-generation nectin-4 targeting antibody drug conjugate.
 
Ding-Wei Ye
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Hua Yang
No Relationships to Disclose
 
Jin Yang
No Relationships to Disclose
 
Tongsen Zheng
No Relationships to Disclose
 
Hongmei Sun
No Relationships to Disclose
 
Yuping Sun
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Pfizer; Roche
 
Guiling Li
No Relationships to Disclose
 
Funan Liu
No Relationships to Disclose
 
Xuechao Wan
Employment - CSPC Pharmaceutical Group Limited.
 
Lan Ge
Employment - CSPC Pharmaceutical Group Limited.
 
Guilan Sun
Employment - CSPC Pharmaceutical Group Limited.
 
Xiao Zhang
Employment - CSPC Pharmaceutical Group Limited.
 
Lei Wang
Employment - CSPC Zhongqi Pharmaceutical Technology Co. Ltd., CSPS Pharmaceutical Group
 
RACHAEL BRAKE
Employment - Corbus Pharmaceuticals; Corbus Pharmaceuticals
Leadership - Corbus pharmaceuticals
Stock and Other Ownership Interests - Corbus pharmaceuticals
Consulting or Advisory Role - Axelia Oncology; Myricx Oncology; Velsera; Velsera
Travel, Accommodations, Expenses - Corbus pharmaceuticals